Adlon Therapeutics L.P. develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We are actively pursuing, through internal research and in partnership with other companies, new medications to address a variety of current and future unmet needs for patients with attention deficit/hyperactivity disorder (ADHD) and related disorders.
Research studies can provide important information on the safety, efficacy, or value of medicines which helps healthcare professionals make informed decisions about their safe and proper use.
To Report an Adverse Event:
Adlon is committed to providing balanced and accurate scientific and clinical information to help you make informed healthcare decisions.